GOVONI, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 26.188
EU - Europa 17.501
AS - Asia 14.037
SA - Sud America 2.442
AF - Africa 394
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 60.629
Nazione #
US - Stati Uniti d'America 25.592
IT - Italia 9.654
SG - Singapore 5.319
CN - Cina 4.439
BR - Brasile 2.040
UA - Ucraina 1.764
DE - Germania 1.676
HK - Hong Kong 1.605
GB - Regno Unito 1.061
TR - Turchia 1.049
FR - Francia 686
FI - Finlandia 575
SE - Svezia 525
RU - Federazione Russa 474
VN - Vietnam 454
ID - Indonesia 318
NL - Olanda 293
MX - Messico 272
CA - Canada 265
PL - Polonia 218
IN - India 201
EG - Egitto 165
JP - Giappone 145
AR - Argentina 144
ES - Italia 137
ZA - Sudafrica 130
BD - Bangladesh 95
BE - Belgio 94
EC - Ecuador 72
CH - Svizzera 66
PK - Pakistan 59
IQ - Iraq 57
AT - Austria 52
AU - Australia 47
CO - Colombia 47
IR - Iran 44
LT - Lituania 44
KR - Corea 36
MY - Malesia 32
VE - Venezuela 32
CZ - Repubblica Ceca 31
PY - Paraguay 31
RO - Romania 31
CL - Cile 30
SA - Arabia Saudita 27
MA - Marocco 26
PE - Perù 26
IE - Irlanda 23
TW - Taiwan 20
UZ - Uzbekistan 17
IL - Israele 15
AE - Emirati Arabi Uniti 14
TN - Tunisia 14
BO - Bolivia 13
KE - Kenya 13
DK - Danimarca 12
DO - Repubblica Dominicana 12
DZ - Algeria 11
GR - Grecia 11
PT - Portogallo 11
CR - Costa Rica 9
JO - Giordania 9
AZ - Azerbaigian 8
EU - Europa 8
KZ - Kazakistan 8
NO - Norvegia 8
BG - Bulgaria 7
BH - Bahrain 7
HN - Honduras 7
LV - Lettonia 7
MD - Moldavia 7
NP - Nepal 7
PA - Panama 7
QA - Qatar 7
NG - Nigeria 6
PH - Filippine 6
RS - Serbia 6
UY - Uruguay 6
AL - Albania 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
GH - Ghana 4
HR - Croazia 4
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BW - Botswana 3
CU - Cuba 3
CY - Cipro 3
GD - Grenada 3
HU - Ungheria 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SC - Seychelles 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
Totale 60.571
Città #
Singapore 2.662
Ashburn 2.374
Fairfield 2.107
Woodbridge 1.926
Jacksonville 1.680
Chandler 1.620
Santa Clara 1.611
Hong Kong 1.592
Beijing 1.415
Houston 1.273
Ann Arbor 1.097
Wilmington 847
Seattle 820
Cambridge 702
Rome 661
Dallas 657
Izmir 606
Milan 579
Nanjing 564
Los Angeles 492
Princeton 424
Munich 351
New York 325
Ferrara 256
Cornaredo 244
Shanghai 242
Jakarta 237
Boardman 228
San Diego 213
Hefei 184
São Paulo 183
Warsaw 178
Nanchang 177
Dearborn 175
Bologna 172
Mexico City 172
Ho Chi Minh City 157
Shenyang 146
Naples 142
Falkenstein 131
Bremen 127
Hebei 121
Turku 118
Buffalo 115
Chicago 115
Addison 114
Tianjin 111
London 105
Changsha 102
Helsinki 102
Tokyo 102
San Mateo 101
Jiaxing 100
Brooklyn 90
Redwood City 90
Moscow 85
Brussels 84
Cairo 84
Hanoi 83
Verona 81
Montreal 79
Palermo 78
Toronto 77
Jinan 71
Rio de Janeiro 71
Cagliari 70
Falls Church 70
Padova 70
Council Bluffs 68
Florence 68
Atlanta 66
Denver 66
Johannesburg 66
San Francisco 64
Frankfurt am Main 62
Norwalk 62
Ankara 61
Mountain View 60
Bari 59
Nuremberg 58
Orem 58
Stockholm 58
Chennai 57
Phoenix 56
The Dalles 56
Boston 55
Alexandria 51
Kunming 49
Turin 49
Guangzhou 48
Napoli 48
Ningbo 47
Poplar 47
Philadelphia 46
Amsterdam 44
Modena 44
Belo Horizonte 43
Dong Ket 43
Cogne 40
Lappeenranta 40
Totale 33.977
Nome #
L’OSTEOARTROSI EROSIVA O INFIAMMATORIA DELLA MANO (MALATTIA DI CRAIN). 3.851
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 1.129
POLIENTESOPATIA IPEROSTOSANTE DISMETABOLICA 1.019
La iperostosi scheletrica idiopatica diffusa (DISH) [Diffuse Idipathic Skeletal Hyperostosis (DISH)] 1.017
L’imaging nel neuro-LES 489
Determinazione della VES con metodo tradizionale di Westergren e Test 1 e comparazione dei valori di DAS28 e 44 in una coorte di pazienti affetti da artrite reumatoide 444
Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs including anti-TNF 357
Stenosi del canale lombare nella poliartropatia iperostosante dismetabolica 326
CASI CLINICI IN REUMATOLOGIA. DALL’IMMAGINE ALLA DIAGNOSI 295
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 291
2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus 282
Osservazioni sull'anemia in corso di artropatia psoriasica. 269
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 251
Colon involvement in systemic sclerosis: Clinical-radiological correlations 236
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 236
La CEFALEA NEL LUPUS ERITEMATOSO SISTEMICO 231
Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database 227
18FDG-PET and large vessel vasculitis: preliminary data on 25 patients 213
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 211
"Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome": Comment on the article by Zhao et al 209
A 49-year-old woman with dyspnoea, palpitations and syncope 207
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 206
Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations 206
Bronchial hyperreactivity in systemic sclerosis patients: Influence of associated Sjogren's syndrome 201
Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: Analysis of a large monocentric cohort with a long-term follow-up 197
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study 196
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 195
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 193
Adult onset Still’s disease 192
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 191
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 190
LA TIPIZZAZIONE LINFOCITARIA IN REUMATOLOGIA 189
Combination treatment with etanercept and an intensive SPA rehabilitation program in active ankylosing spondylitis 188
HLA-G may predict the disease course in patients with early rheumatoid arthritis 187
Prevalenza degli anticorpi anti-citrullina (CCP) nell’artrite reumatoide (A.R.): confronto con pazienti affetti da malattia di Still dell’Adulto. Studio preliminare 187
Connettivite non classificabile e tiroidite autoimmune 187
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 187
L'osteonecrosi asettica in corso di lupus eritematoso sistemico: contributo casistico. 186
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 186
The role of nuclear medicine in the evaluation of neuropsychiatric systemic lupus erythematosus: comment on the article by Sibbitt et al 186
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 182
The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate 182
RM, RM di perfusione e Spect del flusso cerebrale nella valutazione del NeuroLes 182
Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound 181
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 181
Iperuricemie e gotta classificazione, diagnosi e terapia 179
Body weight, gender and response to TNF-  blockers in axial spondyloarthritis 179
L’artrite reumatoide ad esordio senile. 178
CLINIMETRIA DELLE VASCULITI. ASPETTI CLINICI E NOSOGRAFICI 178
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 177
Idiopatic inflammatory myopathies: serological and clinical correlations. Analysis of a monocentric series 176
Il quadro radiologico della mano e del piede nel lupus Eritematoso Sistemico [Radiographic findings of the hand and foot in patients with systemic lupus erythematosus] 176
Central nervous system involvement in Sjögren's syndrome: Unusual, but not unremarkable-clinical, serological characteristics and outcomes in a large cohort of Italian patients 175
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 175
SAPHO syndrome and infections 174
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 173
ANTI-CITRULLINA ANTIBODIES IN ADULT ONSET STILL DISEASE. PRELIMINARY RESULTS 173
Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study 173
Neurological involvement in primary Sjogren's syndrome: Clinical and instrumental evaluation in a cohort of Italian patients 173
Humeral head osteonecrosis caused by electrical injury: A case report 173
Lupus Eritematoso Sistemico 171
Il neuroimaging funzionale nella valutazione del coinvolgimento neurologico in corso di lupus eritematoso sistemico. Risultati preliminari [The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results] 170
Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center 169
Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature 168
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 168
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 167
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database 166
Antibodies to retroviral proteins in Sjögren's syndrome 166
Investigation of Chlamydia pneumonite and Mycoplasma spp. In clinical specimens from patients with arhritis 166
Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation 166
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 165
OSTEOARTROSI E ALTRE FORME DEGENERATIVE 162
Dysfunctional inflammasome in Schnitzler's syndrome 162
Lifestyle and dietary habits of patients with gout followed in rheumatology settings 161
Altered expression and function of P2X7 receptorin patients affected by Systemic Lupus Erythematosus (SLE) 161
SMALL FIBRE SENSORY INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME: HISTOLOGICAL AND NEUROPHISIOLOGIC STUDY 158
Repeated brain conventional MRI and SPECT evaluation in systemic lupus erythematosus patients with and without neuropsychiatric involvement: a follow up study 158
Il ginocchio nella polientesopatia iprostosante dismetabolica: studio xeroradiografico 158
18FDG-PET e vasculiti dei grandi vasi: studio preliminare su 25 pazienti 158
Whipple Disease: Unusual Presentation of a Protean and Sometimes Confusing Disease 157
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 155
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 155
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 154
Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy 153
Malattia di Still dell’adulto: contributo casistico 153
Sternocostoclavicular hyperostosis and the impact of diagnostic delay: Comment on the article by van der Kloot et al 153
Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single center study of a cohort of 71 subjects 152
Overlap fra neuro-LES e sindromi demielinizzanti 152
Mielite dorsale, sindrome di Sneddon e pervietà del foramen ovale in paziente con lupus-like sindrome ed uveiti recidivanti 151
The role of adenosine receptors in rheumatoid arthritis. 151
ARE THERE ANY FACTORS ASSOCIATED WITH HEADACHE IN PATIENTS WITH SLE? 151
Lupus or not lupus? Neuropsychiatric symptom attribution in systemic lupus erythematosus 150
The Evolution of Adult-Onset Still Disease: An Observational and Comparative Study in a Cohort of 76 Italian Patients 148
Medicina nucleare e reumatologia. Integrazioni diagnostico-terapeutiche [The role of nuclear medicine in rheumatology. Diagnostic-therapeutic integration] 148
Adult-onset Still's disease: still a long way to go. Comment on the article 'Adult-onset Still's disease: review of 41 cases' by Riera et al. 147
Ischemia cerebrale focale occipitale in corso di lupus eritematoso sistemico. Ruolo del neuroimaging funzionale nel riconoscimento di lesioni acute in fase precoce 147
Semeiotica della caviglia 147
Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus 147
SNP (1513A > C AND 489C > T) OF P2X7 RECEPTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH SEROSITIS 147
Adherence to treat-to-target management in rheumatoid arthritis and associated factors: Data from the international RA BIODAM cohort 147
Totale 25.265
Categoria #
all - tutte 275.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 21.999
Totale 297.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.515 0 0 0 0 316 519 200 523 183 608 732 434
2021/20224.450 207 543 320 248 169 194 196 280 234 369 341 1.349
2022/20234.659 468 269 202 504 656 602 241 426 576 123 359 233
2023/20243.315 277 327 166 133 200 331 162 288 146 229 193 863
2024/202512.401 474 444 973 592 1.445 1.150 349 681 2.215 1.367 1.534 1.177
2025/202612.840 2.873 1.325 2.776 3.838 2.028 0 0 0 0 0 0 0
Totale 61.567